Book cover for Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210 by

Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B

Volume 210

2025 Released
308 Pages
5-7 Hours
Ebook Unavailable
Audiobook Unavailable
Paperback Unavailable
Academic PressISBN 9780443224201
CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR -Cas systems for metabolic disorders, Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR -Cas systems for cataract and blindness, Advances in CRISPR -Cas systems for muscular dystrophy, Recent development in CRISPR -Cas systems for cardiac disease, Current approaches in CRISPR -Cas systems for diabetes, and much more.

Additional sections cover Advances in CRISPR -Cas systems for liver disease, Advances in CRISPR -Cas systems for lung disease, Advances in CRISPR -Cas systems for kidney diseases, Current progress in CRISPR -Cas systems for rare disease, Advances in CRISPR -Cas systems for heredity disease, Recent progress in CRISPR -Cas systems for neurological disorders, and CRISPR challenges in clinical developments.

Why Readwise Books?

Readwise Books is an ebook & audiobook platform that automatically logs how much you and your friends read, making it fun and easy to read more. Learn more →